PolyPid Ltd.
General ticker "PYPD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $23.4M (TTM average)
PolyPid Ltd. follows the US Stock Market performance with the rate: 53.0%.
Estimated limits based on current volatility of 3.6%: low 4.64$, high 4.99$
Factors to consider:
- Total employees count: 65 as of 2020
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.77$, 7.58$]
- 2026-12-31 to 2027-12-31 estimated range: [2.14$, 6.08$]
Financial Metrics affecting the PYPD estimates:
- Positive: with PPE of -1.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Net income
- Positive: -0.02 < Operating cash flow per share per price, % of 0
- Positive: Investing cash flow per share per price, % of 0 > -0.60
- Negative: negative Industry operating cash flow (median)
Short-term PYPD quotes
Long-term PYPD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $22.87MM | $28.03MM | $32.97MM |
| Operating Income | $-22.87MM | $-28.03MM | $-32.97MM |
| Non-Operating Income | $-0.93MM | $-0.95MM | $-1.20MM |
| Interest Expense | $1.71MM | $1.52MM | $0.69MM |
| R&D Expense | $16.15MM | $22.81MM | $23.81MM |
| Income(Loss) | $-23.80MM | $-28.98MM | $-34.16MM |
| Taxes | $0.07MM | $0.04MM | $0.01MM |
| Net Income(Loss)* | $-23.86MM | $-29.02MM | $-34.17MM |
| Stockholders Equity | $-2.10MM | $7.68MM | $10.97MM |
| Inventory | $0.00MM | $0.00MM | $1.11MM |
| Assets | $15.37MM | $25.22MM | $22.31MM |
| Operating Cash Flow | $-17.24MM | $-21.96MM | $0.00MM |
| Capital expenditure | $0.20MM | $0.08MM | $0.00MM |
| Investing Cash Flow | $3.80MM | $-0.33MM | $0.00MM |
| Financing Cash Flow | $9.98MM | $32.42MM | $0.00MM |
| Earnings Per Share** | $-16.99 | $-4.91 | $-2.09 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.